FSG has partnered with award-winning service Kudos to further enhance the services they provide to their authors.
"FSG has always prided itself on its author services," said Laura Dormer, Editorial Director. "We believe it is important to continue to support authors beyond publication of their articles, and partnering with Kudos will further enhance our ability to do this."
Kudos is a web-based service that helps researchers and their institutions and funders to maximize the visibility and impact of their published articles. Kudos provides a platform for assembling and creating information to help search filtering, for sharing information to drive discovery, and for measuring and monitoring the effect of these activities.
"Future Science Group and Kudos share similar visions in terms of maximising innovation to increase the efficiency of research communication," says Charlie Rapple, Sales & Marketing Director and Co-Founder of Kudos. "By working together, we can make it quicker and easier for their scientific and medical publications to be found, read and applied."
FSG has always been committed to an outstanding author experience, evidenced by a robust peer-review process, commitment to article production quality and exemplary communication throughout the publication process. By partnering with Kudos, FSG is able to further support its authors to build the impact of their articles in an increasingly crowded arena. For further information, go to: http://www.
To register with Kudos and start enriching your articles, go to: http://www.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.